"RetiSpec Raises $10M to Advance AI-Driven Eye Diagnostics for Early Alzheimer's Detection"

RetiSpec closes $10M Series A Funding

RetiSpec (Linkedin), a Canadian software development company, has secured $10 million in Series A funding to advance their AI-driven eye diagnostics technology. Their focus on early detection of neurodegenerative diseases, particularly Alzheimer's disease, makes them an ideal partner for healthcare providers, medical professionals, and research institutions.

Funding Amount: $10 million

Industry: Software Development

Employee Count: 11-50

CEO: Eliav Shaked (CEO Linkedin)

What RetiSpec needs to buy: RetiSpec is seeking collaborations with research institutions and medical centers to further develop and validate their AI-driven eye diagnostics technology. They also require expertise in regulatory compliance and marketing and sales support to successfully commercialize their product in the healthcare industry. Companies specializing in research, regulatory affairs, and healthcare marketing are encouraged to explore partnership opportunities with RetiSpec.